Martin Hansen

Martin Hansen currently serves as Lead Scientist at Ferring Pharmaceuticals, directing pharmaceutical analytic development since January 2019. Prior to this role, Martin held multiple senior scientific positions at Novo Nordisk from August 2005 to January 2019, focusing on haemophilia research, bioanalysis, and CMC bioassay. Martin's early career included a postdoctoral position at the University of Cambridge and a research fellowship at Rigshospitalet, which included Ph.D. studies at Aarhus University. Martin holds a Ph.D. in Molecular Biology and an M.Sc. in Biotechnology and Molecular Biology from Aarhus University, along with a postdoctoral degree from the University of Cambridge.